New data shows Telomir-1 fully reverses STAT1 gene silencing by DNA methylation – a key immune regulator suppressed in cancer – delivering stronger epigenetic effects than Paclitaxel or Rapamycin in ...
Researchers have identified adaptive traits in cancer cells that help tumors resist immunotherapy drugs after extended targeted treatment, revealing new hurdles to effective cancer treatment. A ...
The findings show that prolonged targeted therapy in patients with head and neck cancer can heighten tumor alertness, ...
By restoring STAT1 activity, Telomir-1 may be reawakening the body's built-in tumor suppressor system-allowing immune cells to once again recognize, target, and eliminate cancer. This mechanism offers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results